Home › Companies › UNITED THERAPEUTICS CORP. › 2023-2024

UNITED THERAPEUTICS CORP. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and UNITED THERAPEUTICS CORP.’s Form 8-K, filed June 27, 2024 (Item 5.07 on EDGAR). Page generated October 18, 2026.

  • 15Ballot items
  • 550Asset managers
  • 9,433Fund votes
  • June 26, 2024Meeting date

Results at a glance

Meeting of June 26, 2024: 15 items on UNITED THERAPEUTICS CORP.’s Form 8-K, filed June 27, 2024: 15 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore UNITED THERAPEUTICS CORP. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by UNITED THERAPEUTICS CORP.

These tallies are UNITED THERAPEUTICS CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 27, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

UNITED THERAPEUTICS CORP. — official shareholder meeting results, meeting held June 26, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Christopher Causey 32,655,7775,007,45123,624 --899,233 87%Not verified—
Elect Director: Raymond Dwek 34,539,3313,124,02023,501 --899,233 92%Not verified—
Elect Director: Richard Giltner 35,926,9441,735,49524,413 --899,233 95%Not verified—
Elect Director: Ray Kurzweil 34,881,8792,780,36724,606 --899,233 93%Not verified—
Elect Director: Jan Malcolm 37,494,516166,92525,411 --899,233 99.5%Not verified—
Elect Director: Linda Maxwell 37,281,239380,26125,352 --899,233 99%Not verified—
Elect Director: Nilda Mesa 36,692,631968,80025,421 --899,233 97%Not verified—
Elect Director: Judy Olian 37,346,987314,60325,262 --899,233 99.1%Not verified—
Elect Director: Christopher Patusky 33,657,3844,005,88223,586 --899,233 89%Not verified—
Elect Director: Martine Rothblatt 35,207,7352,456,73322,384 --899,233 93%Not verified—
Elect Director: Louis Sullivan 34,414,9003,233,84438,108 --899,233 91%Not verified—
Elect Director: Tommy Thompson 36,267,7571,393,31425,781 --899,233 96%Not verified—
2. An advisory resolution to approve executive compensation 35,662,9951,974,53049,327 --899,233 95%Not verified—
3. Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan 32,982,7054,663,24840,899 --899,233 88%Not verified—
4. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2024 37,189,7911,373,45322,841 ---- 96%Not verified—

This meeting is also recorded here as June 27, 2024; both records come from the same filing, so the date should be checked against it.

Source: UNITED THERAPEUTICS CORP., Form 8-K, filed with the SEC on June 27, 2024 — read the filing on EDGAR.

How asset managers voted at the UNITED THERAPEUTICS CORP. 2023-2024 meeting

Each item below shows how the 550 asset managers that disclosed a UNITED THERAPEUTICS CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Christopher Causey

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 5 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

FOR 87%
FOR: 32,655,777AGAINST: 5,007,451
Details: description as filed, official tally, votes by 135 asset managers

Description as filed by funds: Election of Directors: Christopher Causey

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Christopher Causey”): 32,655,777 for, 5,007,451 against, per its Form 8-K filed June 27, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 135 asset managers below reported 14,305,867 for, 1,348,573 against, 21,006 abstained.

FOR
FOR: 14,305,867AGAINST: 1,348,573ABSTAIN: 21,006
Largest asset managers voting on “Election of Directors: Christopher Causey” at UNITED THERAPEUTICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,021,6200 00For
BlackRock1,892,6750 00For
Fidelity1,352,4800 00For
State Street1,123610,074 00Against
Capitol Series Trust542,6420 00For
Pacer Funds Trust496,3840 00For
TIAA0402,649 00Against
Charles Schwab397,4170 00For
Dimensional353,2410 00For
Hartford343,7960 00For
First Trust308,0690 00For
Invesco292,6640 00For
JANUS INVESTMENT FUND196,5740 00For
John Hancock159,5580 00For
SEI126,3100 00For
AQR117,4290 00For
Jackson National10,496106,133 00Mixed
Principal82,2660 00For
AIG/SunAmerica82,0480 00For
Equitable80,3020 00For
Prudential/PGIM71,1770 00For
JPMorgan67,3230 00For
AB RELATIVE VALUE FUND, INC.67,2700 00For
Northwestern Mutual61,9540 00For
Brighthouse35,2822,292 20,3140Mixed

Showing the 25 largest of 135 asset managers. See all 135 in the interactive database.

2. Elect Director: Christopher Patusky

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%
FOR: 33,657,384AGAINST: 4,005,882
Details: description as filed, official tally, votes by 134 asset managers

Description as filed by funds: Election of Directors: Christopher Patusky

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Christopher Patusky”): 33,657,384 for, 4,005,882 against, per its Form 8-K filed June 27, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 134 asset managers below reported 14,937,985 for, 701,955 against, 21,006 abstained.

FOR
FOR: 14,937,985AGAINST: 701,955ABSTAIN: 21,006
Largest asset managers voting on “Election of Directors: Christopher Patusky” at UNITED THERAPEUTICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,021,6200 00For
BlackRock1,892,6750 00For
Fidelity1,352,4800 00For
State Street1,123610,074 00Against
Capitol Series Trust542,6420 00For
Pacer Funds Trust496,3840 00For
TIAA402,6490 00For
Charles Schwab397,4170 00For
Dimensional353,2410 00For
Hartford343,7960 00For
First Trust308,0690 00For
Invesco292,6640 00For
JANUS INVESTMENT FUND196,5740 00For
John Hancock159,5580 00For
SEI126,3100 00For
AQR117,4290 00For
Jackson National116,6290 00For
Principal82,2660 00For
AIG/SunAmerica82,0480 00For
Equitable80,3020 00For
Prudential/PGIM71,1770 00For
JPMorgan67,3230 00For
AB RELATIVE VALUE FUND, INC.67,2700 00For
Northwestern Mutual61,9540 00For
Brighthouse37,5740 20,3140Mixed

Showing the 25 largest of 134 asset managers. See all 134 in the interactive database.

3. Elect Director: Jan Malcolm

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 37,494,516AGAINST: 166,925
Details: description as filed, official tally, votes by 134 asset managers

Description as filed by funds: Election of Directors: Jan Malcolm

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Jan Malcolm”): 37,494,516 for, 166,925 against, per its Form 8-K filed June 27, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 134 asset managers below reported 15,639,940 for, 21,006 abstained.

FOR
FOR: 15,639,940ABSTAIN: 21,006
Largest asset managers voting on “Election of Directors: Jan Malcolm” at UNITED THERAPEUTICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,021,6200 00For
BlackRock1,892,6750 00For
Fidelity1,352,4800 00For
State Street611,1970 00For
Capitol Series Trust542,6420 00For
Pacer Funds Trust496,3840 00For
TIAA402,6490 00For
Charles Schwab397,4170 00For
Dimensional353,2410 00For
Hartford343,7960 00For
First Trust308,0690 00For
Invesco292,6640 00For
JANUS INVESTMENT FUND196,5740 00For
John Hancock159,5580 00For
SEI126,3100 00For
AQR117,4290 00For
Jackson National116,6290 00For
Principal82,2660 00For
AIG/SunAmerica82,0480 00For
Equitable80,3020 00For
Prudential/PGIM71,1770 00For
JPMorgan67,3230 00For
AB RELATIVE VALUE FUND, INC.67,2700 00For
Northwestern Mutual61,9540 00For
Brighthouse37,5740 20,3140Mixed

Showing the 25 largest of 134 asset managers. See all 134 in the interactive database.

4. Elect Director: Judy Olian

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 37,346,987AGAINST: 314,603
Details: description as filed, official tally, votes by 134 asset managers

Description as filed by funds: Election of Directors: Judy Olian

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Judy Olian”): 37,346,987 for, 314,603 against, per its Form 8-K filed June 27, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 134 asset managers below reported 15,632,282 for, 7,658 against, 21,006 abstained.

FOR
FOR: 15,632,282AGAINST: 7,658ABSTAIN: 21,006
Largest asset managers voting on “Election of Directors: Judy Olian” at UNITED THERAPEUTICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,021,6200 00For
BlackRock1,892,6750 00For
Fidelity1,352,4800 00For
State Street611,1970 00For
Capitol Series Trust542,6420 00For
Pacer Funds Trust496,3840 00For
TIAA402,6490 00For
Charles Schwab397,4170 00For
Dimensional353,2410 00For
Hartford343,7960 00For
First Trust308,0690 00For
Invesco292,6640 00For
JANUS INVESTMENT FUND196,5740 00For
John Hancock159,5580 00For
SEI126,3100 00For
AQR117,4290 00For
Jackson National116,6290 00For
Principal82,2660 00For
AIG/SunAmerica82,0480 00For
Equitable80,3020 00For
Prudential/PGIM71,1770 00For
JPMorgan67,3230 00For
AB RELATIVE VALUE FUND, INC.67,2700 00For
Northwestern Mutual61,9540 00For
Brighthouse37,5740 20,3140Mixed

Showing the 25 largest of 134 asset managers. See all 134 in the interactive database.

5. Elect Director: Linda Maxwell

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 37,281,239AGAINST: 380,261
Details: description as filed, official tally, votes by 134 asset managers

Description as filed by funds: Election of Directors: Linda Maxwell

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Linda Maxwell”): 37,281,239 for, 380,261 against, per its Form 8-K filed June 27, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 134 asset managers below reported 15,632,282 for, 7,658 against, 21,006 abstained.

FOR
FOR: 15,632,282AGAINST: 7,658ABSTAIN: 21,006
Largest asset managers voting on “Election of Directors: Linda Maxwell” at UNITED THERAPEUTICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,021,6200 00For
BlackRock1,892,6750 00For
Fidelity1,352,4800 00For
State Street611,1970 00For
Capitol Series Trust542,6420 00For
Pacer Funds Trust496,3840 00For
TIAA402,6490 00For
Charles Schwab397,4170 00For
Dimensional353,2410 00For
Hartford343,7960 00For
First Trust308,0690 00For
Invesco292,6640 00For
JANUS INVESTMENT FUND196,5740 00For
John Hancock159,5580 00For
SEI126,3100 00For
AQR117,4290 00For
Jackson National116,6290 00For
Principal82,2660 00For
AIG/SunAmerica82,0480 00For
Equitable80,3020 00For
Prudential/PGIM71,1770 00For
JPMorgan67,3230 00For
AB RELATIVE VALUE FUND, INC.67,2700 00For
Northwestern Mutual61,9540 00For
Brighthouse37,5740 20,3140Mixed

Showing the 25 largest of 134 asset managers. See all 134 in the interactive database.

6. Elect Director: Louis Sullivan

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%
FOR: 34,414,900AGAINST: 3,233,844
Details: description as filed, official tally, votes by 134 asset managers

Description as filed by funds: Election of Directors: Louis Sullivan

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Louis Sullivan”): 34,414,900 for, 3,233,844 against, per its Form 8-K filed June 27, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 134 asset managers below reported 14,938,423 for, 701,517 against, 21,006 abstained.

FOR
FOR: 14,938,423AGAINST: 701,517ABSTAIN: 21,006
Largest asset managers voting on “Election of Directors: Louis Sullivan” at UNITED THERAPEUTICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,021,6200 00For
BlackRock1,892,6750 00For
Fidelity1,352,4800 00For
State Street1,123610,074 00Against
Capitol Series Trust542,6420 00For
Pacer Funds Trust496,3840 00For
TIAA402,6490 00For
Charles Schwab397,4170 00For
Dimensional353,2410 00For
Hartford343,7960 00For
First Trust308,0690 00For
Invesco292,6640 00For
JANUS INVESTMENT FUND196,5740 00For
John Hancock159,5580 00For
SEI126,3100 00For
AQR117,4290 00For
Jackson National116,6290 00For
Principal82,2660 00For
AIG/SunAmerica82,0480 00For
Equitable80,3020 00For
Prudential/PGIM71,1770 00For
JPMorgan67,3230 00For
AB RELATIVE VALUE FUND, INC.67,2700 00For
Northwestern Mutual61,9540 00For
Brighthouse37,5740 20,3140Mixed

Showing the 25 largest of 134 asset managers. See all 134 in the interactive database.

7. Elect Director: Martine Rothblatt

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 35,207,735AGAINST: 2,456,733
Details: description as filed, official tally, votes by 134 asset managers

Description as filed by funds: Election of Directors: Martine Rothblatt

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Martine Rothblatt”): 35,207,735 for, 2,456,733 against, per its Form 8-K filed June 27, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 134 asset managers below reported 15,572,942 for, 66,998 against, 21,006 abstained.

FOR
FOR: 15,572,942AGAINST: 66,998ABSTAIN: 21,006
Largest asset managers voting on “Election of Directors: Martine Rothblatt” at UNITED THERAPEUTICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,021,6200 00For
BlackRock1,892,6750 00For
Fidelity1,352,4800 00For
State Street611,11285 00For
Capitol Series Trust542,6420 00For
Pacer Funds Trust496,3840 00For
TIAA402,6490 00For
Charles Schwab397,4170 00For
Dimensional353,2410 00For
Hartford343,7960 00For
First Trust308,0690 00For
Invesco292,6640 00For
JANUS INVESTMENT FUND196,5740 00For
John Hancock159,5580 00For
SEI126,3100 00For
AQR117,4290 00For
Jackson National116,6290 00For
Principal82,2660 00For
AIG/SunAmerica82,0480 00For
Equitable80,3020 00For
Prudential/PGIM71,1770 00For
JPMorgan67,3230 00For
AB RELATIVE VALUE FUND, INC.67,2700 00For
Northwestern Mutual61,9540 00For
Brighthouse37,5740 20,3140Mixed

Showing the 25 largest of 134 asset managers. See all 134 in the interactive database.

8. Elect Director: Nilda Mesa

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 36,692,631AGAINST: 968,800
Details: description as filed, official tally, votes by 134 asset managers

Description as filed by funds: Election of Directors: Nilda Mesa

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Nilda Mesa”): 36,692,631 for, 968,800 against, per its Form 8-K filed June 27, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 134 asset managers below reported 15,618,681 for, 21,259 against, 21,006 abstained.

FOR
FOR: 15,618,681AGAINST: 21,259ABSTAIN: 21,006
Largest asset managers voting on “Election of Directors: Nilda Mesa” at UNITED THERAPEUTICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,021,6200 00For
BlackRock1,892,6750 00For
Fidelity1,352,4800 00For
State Street611,1970 00For
Capitol Series Trust542,6420 00For
Pacer Funds Trust496,3840 00For
TIAA402,6490 00For
Charles Schwab397,4170 00For
Dimensional353,2410 00For
Hartford343,7960 00For
First Trust308,0690 00For
Invesco292,6640 00For
JANUS INVESTMENT FUND196,5740 00For
John Hancock159,5580 00For
SEI126,3100 00For
AQR117,4290 00For
Jackson National116,6290 00For
Principal82,2660 00For
AIG/SunAmerica82,0480 00For
Equitable80,3020 00For
Prudential/PGIM71,1770 00For
JPMorgan67,3230 00For
AB RELATIVE VALUE FUND, INC.67,2700 00For
Northwestern Mutual61,9540 00For
Brighthouse37,5740 20,3140Mixed

Showing the 25 largest of 134 asset managers. See all 134 in the interactive database.

9. Elect Director: Ray Kurzweil

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 34,881,879AGAINST: 2,780,367
Details: description as filed, official tally, votes by 134 asset managers

Description as filed by funds: Election of Directors: Ray Kurzweil

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Ray Kurzweil”): 34,881,879 for, 2,780,367 against, per its Form 8-K filed June 27, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 134 asset managers below reported 14,956,876 for, 683,064 against, 21,006 abstained.

FOR
FOR: 14,956,876AGAINST: 683,064ABSTAIN: 21,006
Largest asset managers voting on “Election of Directors: Ray Kurzweil” at UNITED THERAPEUTICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,021,6200 00For
BlackRock1,892,6750 00For
Fidelity1,352,4800 00For
State Street1,123610,074 00Against
Capitol Series Trust542,6420 00For
Pacer Funds Trust496,3840 00For
TIAA402,6490 00For
Charles Schwab397,4170 00For
Dimensional353,2410 00For
Hartford343,7960 00For
First Trust308,0690 00For
Invesco292,6640 00For
JANUS INVESTMENT FUND196,5740 00For
John Hancock159,5580 00For
SEI126,3100 00For
AQR117,4290 00For
Jackson National116,6290 00For
Principal82,2660 00For
AIG/SunAmerica82,0480 00For
Equitable80,3020 00For
Prudential/PGIM71,1770 00For
JPMorgan67,3230 00For
AB RELATIVE VALUE FUND, INC.67,2700 00For
Northwestern Mutual61,9540 00For
Brighthouse37,5740 20,3140Mixed

Showing the 25 largest of 134 asset managers. See all 134 in the interactive database.

10. Elect Director: Raymond Dwek

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%
FOR: 34,539,331AGAINST: 3,124,020
Details: description as filed, official tally, votes by 134 asset managers

Description as filed by funds: Election of Directors: Raymond Dwek

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Raymond Dwek”): 34,539,331 for, 3,124,020 against, per its Form 8-K filed June 27, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 134 asset managers below reported 14,938,423 for, 701,517 against, 21,006 abstained.

FOR
FOR: 14,938,423AGAINST: 701,517ABSTAIN: 21,006
Largest asset managers voting on “Election of Directors: Raymond Dwek” at UNITED THERAPEUTICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,021,6200 00For
BlackRock1,892,6750 00For
Fidelity1,352,4800 00For
State Street1,123610,074 00Against
Capitol Series Trust542,6420 00For
Pacer Funds Trust496,3840 00For
TIAA402,6490 00For
Charles Schwab397,4170 00For
Dimensional353,2410 00For
Hartford343,7960 00For
First Trust308,0690 00For
Invesco292,6640 00For
JANUS INVESTMENT FUND196,5740 00For
John Hancock159,5580 00For
SEI126,3100 00For
AQR117,4290 00For
Jackson National116,6290 00For
Principal82,2660 00For
AIG/SunAmerica82,0480 00For
Equitable80,3020 00For
Prudential/PGIM71,1770 00For
JPMorgan67,3230 00For
AB RELATIVE VALUE FUND, INC.67,2700 00For
Northwestern Mutual61,9540 00For
Brighthouse37,5740 20,3140Mixed

Showing the 25 largest of 134 asset managers. See all 134 in the interactive database.

11. Elect Director: Richard Giltner

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 35,926,944AGAINST: 1,735,495
Details: description as filed, official tally, votes by 134 asset managers

Description as filed by funds: Election of Directors: Richard Giltner

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Richard Giltner”): 35,926,944 for, 1,735,495 against, per its Form 8-K filed June 27, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 134 asset managers below reported 15,592,826 for, 47,114 against, 21,006 abstained.

FOR
FOR: 15,592,826AGAINST: 47,114ABSTAIN: 21,006
Largest asset managers voting on “Election of Directors: Richard Giltner” at UNITED THERAPEUTICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,021,6200 00For
BlackRock1,892,6750 00For
Fidelity1,352,4800 00For
State Street611,11285 00For
Capitol Series Trust542,6420 00For
Pacer Funds Trust496,3840 00For
TIAA402,6490 00For
Charles Schwab397,4170 00For
Dimensional353,2410 00For
Hartford343,7960 00For
First Trust308,0690 00For
Invesco292,6640 00For
JANUS INVESTMENT FUND196,5740 00For
John Hancock159,5580 00For
SEI126,3100 00For
AQR117,4290 00For
Jackson National116,6290 00For
Principal82,2660 00For
AIG/SunAmerica82,0480 00For
Equitable80,3020 00For
Prudential/PGIM71,1770 00For
JPMorgan67,3230 00For
AB RELATIVE VALUE FUND, INC.67,2700 00For
Northwestern Mutual61,9540 00For
Brighthouse37,5740 20,3140Mixed

Showing the 25 largest of 134 asset managers. See all 134 in the interactive database.

12. Elect Director: Tommy Thompson

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 36,267,757AGAINST: 1,393,314
Details: description as filed, official tally, votes by 134 asset managers

Description as filed by funds: Election of Directors: Tommy Thompson

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Tommy Thompson”): 36,267,757 for, 1,393,314 against, per its Form 8-K filed June 27, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 134 asset managers below reported 15,415,115 for, 224,825 against, 21,006 abstained.

FOR
FOR: 15,415,115AGAINST: 224,825ABSTAIN: 21,006
Largest asset managers voting on “Election of Directors: Tommy Thompson” at UNITED THERAPEUTICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,021,6200 00For
BlackRock1,892,6750 00For
Fidelity1,352,4800 00For
State Street611,11285 00For
Capitol Series Trust542,6420 00For
Pacer Funds Trust496,3840 00For
TIAA402,6490 00For
Charles Schwab397,4170 00For
Dimensional353,2410 00For
Hartford343,7960 00For
First Trust308,0690 00For
Invesco292,6640 00For
JANUS INVESTMENT FUND196,5740 00For
John Hancock159,5580 00For
SEI126,3100 00For
AQR117,4290 00For
Jackson National116,6290 00For
Principal82,2660 00For
AIG/SunAmerica82,0480 00For
Equitable22,33157,971 00Mixed
Prudential/PGIM71,1770 00For
JPMorgan67,3230 00For
AB RELATIVE VALUE FUND, INC.067,270 00Against
Northwestern Mutual61,9540 00For
Brighthouse37,5740 20,3140Mixed

Showing the 25 largest of 134 asset managers. See all 134 in the interactive database.

13. 3. Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock…

Outcome not verifiedFund totals may overlapCOMPENSATIONReported outcome: Not verified

Combines 5 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%
FOR: 32,982,705AGAINST: 4,663,248
Details: description as filed, official tally, votes by 146 asset managers

Description as filed by funds: APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE UNITED THERAPEUTICS CORPORATION AMENDED AND RESTATED 2015 STOCK INCENTIVE PLAN.

UNITED THERAPEUTICS CORP.’s own tally for this item (“3. Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan”): 32,982,705 for, 4,663,248 against, per its Form 8-K filed June 27, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 134 asset managers voting on “APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE UNITED THERAPEUTICS CORPORATION AMENDED AND RESTATED 2015 STO” at UNITED THERAPEUTICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,021,6200 00For
BlackRock1,892,6750 00For
Fidelity1,352,4800 00For
State Street1,123610,074 00Against
Capitol Series Trust542,6420 00For
Pacer Funds Trust0496,384 00Against
TIAA402,6490 00For
Charles Schwab397,4170 00For
Dimensional353,2410 00For
Hartford343,7960 00For
First Trust308,0690 00For
Invesco292,6640 00For
JANUS INVESTMENT FUND196,5740 00For
John Hancock159,5580 00For
SEI126,3100 00For
AQR117,4290 00For
Jackson National116,6290 00For
Principal82,2660 00For
AIG/SunAmerica82,0480 00For
Equitable80,3020 00For
Prudential/PGIM71,1770 00For
JPMorgan67,3230 00For
AB RELATIVE VALUE FUND, INC.67,2700 00For
Northwestern Mutual61,9540 00For
Brighthouse37,5740 20,3140Mixed

Fund voting reports, all 134 managers: 14,327,716 for, 1,340,159 against, 21,006 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 12 asset managers voting on “APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE UNITED THERAPEUTICS CORPORATION AMENDED AND RESTATED 2015 STO” at UNITED THERAPEUTICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Palo Alto Investors LP266,9140 00For
Eversept Partners, LP252,7200 00For
Summit Street Capital Management, LLC90,0390 00For
Erste Asset Management GmbH24,6630 00For
New Vernon Capital Holdings II LLC2,6970 00For
Jackson Creek Investment Advisors LLC2,5370 00For
Regime de rentes du Mouvement Desjardins0617 00Against
First Light Asset Management, LLC1190 00For
Boltwood Capital Management100 00For
LATHROP INVESTMENT MANAGEMENT CORP00 00--
LEAVELL INVESTMENT MANAGEMENT, INC.00 100Abstain
Pinnacle Family Advisors, LLC90 00For

Institutional-manager reports, all 12 managers: 639,708 for, 617 against, 10 abstained, 10 unknown.

14. 2. An advisory resolution to approve executive compensation

Outcome not verifiedFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Combines 14 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 35,662,995AGAINST: 1,974,530
Details: description as filed, official tally, votes by 548 asset managers

Description as filed by funds: Advisory resolution to approve executive compensation.

UNITED THERAPEUTICS CORP.’s own tally for this item (“2. An advisory resolution to approve executive compensation”): 35,662,995 for, 1,974,530 against, per its Form 8-K filed June 27, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 133 asset managers voting on “Advisory resolution to approve executive compensation.” at UNITED THERAPEUTICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,021,6200 00For
BlackRock1,892,6750 00For
Fidelity1,352,4800 00For
State Street611,1970 00For
Capitol Series Trust542,6420 00For
Pacer Funds Trust496,3840 00For
TIAA402,6490 00For
Charles Schwab397,4170 00For
Dimensional353,2410 00For
Hartford343,7960 00For
First Trust308,0690 00For
Invesco292,6640 00For
JANUS INVESTMENT FUND196,5740 00For
John Hancock159,5580 00For
SEI126,3100 00For
AQR117,4290 00For
Jackson National116,6290 00For
Principal82,2660 00For
AIG/SunAmerica82,0480 00For
Equitable80,3020 00For
Prudential/PGIM71,1770 00For
JPMorgan67,3230 00For
AB RELATIVE VALUE FUND, INC.67,2700 00For
Northwestern Mutual61,9540 00For
Brighthouse37,5740 20,3140Mixed

Fund voting reports, all 133 managers: 15,649,537 for, 18,266 against, 21,006 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 450 asset managers voting on “Advisory resolution to approve executive compensation.” at UNITED THERAPEUTICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Wellington2,893,6490 00For
BlackRock1,969,721293 00For
Renaissance1,865,6440 00For
State Street1,742,4680 00For
GEODE CAPITAL MANAGEMENT, LLC828,6090 00For
Fidelity813,2780 00For
Man Group plc0797,860 00Against
Janus Henderson633,3280 00For
FULLER & THALER ASSET MANAGEMENT, INC.566,1340 00For
AQR513,5140 00For
LSV ASSET MANAGEMENT464,49319,070 00For
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC470,8970 00For
Nuveen463,8830 00For
MELLON INVESTMENTS Corp450,9700 00For
Avoro Capital Advisors LLC431,1710 00For
AllianceBernstein428,5800 00For
Swedbank Robur Fonder AB411,9550 00For
NORDEA INVESTMENT MANAGEMENT AB409,5870 00For
Charles Schwab400,3530 00For
Northern Trust327,226440 00For
Invesco322,2080 00For
Citadel307,6510 00For
Palo Alto Investors LP266,9140 00For
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM0264,573 00Against
Eversept Partners, LP252,7200 00For

Institutional-manager reports, all 450 managers: 23,902,389 for, 1,976,897 against, 514 abstained, 274 not voted, 11 unknown. Showing the 25 largest; see all in the interactive database.

15. 4. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm…

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

Combines 6 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 37,189,791AGAINST: 1,373,453
Details: description as filed, official tally, votes by 135 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2024.

UNITED THERAPEUTICS CORP.’s own tally for this item (“4. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2024”): 37,189,791 for, 1,373,453 against, per its Form 8-K filed June 27, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 135 asset managers below reported 15,606,323 for, 48,117 against, 21,006 abstained.

FOR
FOR: 15,606,323AGAINST: 48,117ABSTAIN: 21,006
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ” at UNITED THERAPEUTICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,021,6200 00For
BlackRock1,892,6750 00For
Fidelity1,352,4800 00For
State Street611,11285 00For
Capitol Series Trust542,6420 00For
Pacer Funds Trust496,3840 00For
TIAA402,6490 00For
Charles Schwab397,4170 00For
Dimensional353,2410 00For
Hartford343,7960 00For
First Trust308,0690 00For
Invesco292,6640 00For
JANUS INVESTMENT FUND196,5740 00For
John Hancock159,5580 00For
SEI126,3100 00For
AQR117,4290 00For
Jackson National116,6290 00For
Principal82,2660 00For
AIG/SunAmerica82,0480 00For
Equitable80,3020 00For
Prudential/PGIM71,1770 00For
JPMorgan67,3230 00For
AB RELATIVE VALUE FUND, INC.67,2700 00For
Northwestern Mutual61,9540 00For
Brighthouse35,2822,292 20,3140Mixed

Showing the 25 largest of 135 asset managers. See all 135 in the interactive database.

Not shown here: this season’s fund filings also report 1 item from the meeting of June 26, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.

Largest UNITED THERAPEUTICS CORP. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 44,204,517 shares outstanding at the time of that meeting.

Fund voting reports: top UNITED THERAPEUTICS CORP. shareholders by shares voted on “APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE UNITED THERAPEUTICS CORPORATION AMENDED AND…”, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 13.62%
2BlackRock 4.28%
3Fidelity 3.06%
4State Street 1.38%
5Capitol Series Trust 1.23%
6Pacer Funds Trust 1.12%
7TIAA 0.91%
8Charles Schwab 0.90%
9Dimensional 0.80%
10Hartford 0.78%
Institutional-manager reports: top UNITED THERAPEUTICS CORP. shareholders by shares voted on “Advisory resolution to approve executive compensation.”, 2023-2024
#Asset manager % of shares outstanding
1Wellington 6.55%
2BlackRock 4.46%
3Renaissance 4.22%
4State Street 3.94%
5GEODE CAPITAL MANAGEMENT, LLC 1.87%
6Fidelity 1.84%
7Man Group plc 1.80%
8Janus Henderson 1.43%
9FULLER & THALER ASSET MANAGEMENT, INC. 1.28%
10AQR 1.16%

Reported UNITED THERAPEUTICS CORP. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

UNITED THERAPEUTICS CORP. holdings and ownership disclosed for the 2023-2024 proxy season
Holder % outstanding Disclosure
BlackRock 12.11% 13F
Vanguard Group 10.00% 13F
Martine Rothblatt 7.98% DEF14A
Wellington Management 7.72% 13F
Avoro Capital Advisors LLC 6.47% DEF14A
FMR LLC 5.25% DEF14A
Renaissance Technologies 4.87% 13F
State Street 4.38% 13F
Michael Benkowitz 1.86% DEF14A
James Edgemond 1.48% DEF14A

Percentages above are of 44,204,517 shares outstanding, as reported by UNITED THERAPEUTICS CORP. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from UNITED THERAPEUTICS CORP.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At UNITED THERAPEUTICS CORP.'s shareholder meeting held June 26, 2024, in the 2023-2024 proxy season, 550 asset managers reported how they voted on 15 ballot items in their SEC Form N-PX filings, covering 9,433 separate fund positions. On the most widely held item on that ballot — Advisory resolution to approve executive compensation. — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: UNITED THERAPEUTICS CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 27, 2024.

UNITED THERAPEUTICS CORP. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.